The oral presentation will highlight SELVA, a 24-week, Phase 3, single-arm, baseline-controlled clinical trial of QTORIN™ rapamycin 3.9% anhydrous gel for the treatment of microcystic lymphatic ...

MANILA, Philippines — The highest heat index on Friday is forecast at 41°C in two areas, according to the Philippine Atmospheric, Geophysical and Astronomical Services Administration (Pagasa ...

SINGAPORE: Three finswimmers and their coaches said on Thursday (Mar 20) they would cooperate fully with police investigations and that they believe “the truth will prevail”, a day after it ...

DALLAS, March 20, 2025 /PRNewswire/ -- Nanoscope Therapeutics Inc., a biotechnology company committed to restoring vision in blind patients in real-world settings by developing and commercializing ...

Scribe’s partners include Eli Lilly-owned Prevail Therapeutics (an up to $1.5 billion neuro-focused collaboration launched in 2023)—and Sanofi, from which Scribe in January received a ...

This follow-up to the Prevail 2 adds LTE and steps up to a larger display. Other features of this affordable Android phone are similar, including 5-megapixel camera, front camera, memory card slot ...

BOSTON, March 15, 2025 /PRNewswire/ -- Skyhawk Therapeutics, Inc., a clinical-stage biotechnology company developing novel small molecule therapies designed to modulate critical RNA targets ...

Skyhawk presents today on its novel SKY-0515 small molecule RNA splicing modulator targeting Huntington's Disease to members of the Huntington's Disease Youth Organization, at the annual HYDO ...

Viking Therapeutics' stock declined by 37% following a downgrade to "hold" in December, anticipating competitive pressures from Novo Nordisk's CagriSema Phase 3 results. The company's GIP/GLP-1 ...